Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of Barzolvolimab in Patients With Atopic Dermatitis

ClinicalTrials.gov ID: NCT06727552

Public ClinicalTrials.gov record NCT06727552. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 3:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients With Moderate to Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis

Study identification

NCT ID
NCT06727552
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celldex Therapeutics
Industry
Enrollment
131 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 17, 2024
Primary completion
May 5, 2026
Completion
Nov 30, 2026
Last update posted
Aug 10, 2026

2024 – 2026

United States locations

U.S. sites
33
U.S. states
14
U.S. cities
31
Facility City State ZIP Site status
Cahaba Dermatology & Skin Health Center, LLC Birmingham Alabama 35244
Ohara Aivaz MD Dermatology Beverly Hills California 90212
Advanced Dermatology Center - Burbank Burbank California 91506
310 Clinical Research Inglewood California 90301
Avance Trials Laguna Niguel California 92677
LA Universal Research Center, Inc. Los Angeles California 90057
UCLA Division of Dermatology Los Angeles California 90089
Dynasty Dermatology Pasadena California 91105
Acclaim Clinical Research San Diego California 92120
FOMAT Medical Research - Allergy, Asthma, & Immunology Medical Group Ventura California 93003
Focus Clinical Research West Hills California 91307
Direct Helpers Research Center Hialeah Florida 33012
International Dermatology Research Inc - Miami Miami Lakes Florida 33144
Sarasota Clinical Research Sarasota Florida 34233
Well Pharma Medical Research Corporation South Miami Florida 33173
Centricity Research Columbus Dermatology Columbus Georgia 31904
Georgia Skin and Cancer Clinic Savannah Georgia 31419
Treasure Valley Medical Research Boise Idaho 83706
Center for Medical Dermatology + Immunology Research Chicago Illinois 60657
Sneeze Wheeze and Itch Associates LLC Normal Illinois 61761
Equity Medical LLC Bowling Green Kentucky 42104
Allergy and Asthma Specialists PSC Owensboro Kentucky 42301
Onyx Clinical Research - Michigan Flint Michigan 48532
Revival Research Institute, LLC Troy Michigan 48084
Excel Clinical Research Las Vegas Nevada 89109
Equity Medical, LLC New York New York 10023
OptiSkin Medical New York New York 10128
Bernstein Clinical Research Center, LLC Cincinnati Ohio 45236
Palmetto Clinical Trial Services LLC Simpsonville South Carolina 29615
Zenos Clinical Research Dallas Texas 75230
Sienna Dermatology Sugar Land Texas 77479
Center for Clinical Studies LTD.LLP Webster Texas 77598
Jordan Valley Dermatology Center - South Jordan South Jordan Utah 84095

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06727552, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2026 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06727552 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →